Benefits of Adapted Physical Activity for Chronic Osteoarticular Pain in Patients With Multiple Myeloma

NCT ID: NCT05548686

Last Updated: 2022-09-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-30

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pain is one of the most frequent symptoms leading patients to consult a doctor, particularly in rheumatology and cancerology. When it becomes chronic, pain is the cause of a major emotional and physical invasion, with harmful repercussions on the family, social and professional levels. It is therefore necessary to be able to propose different therapies.

For many years, non-medicinal techniques have been proving their benefits and their central role in the treatment of chronic pain. Physical activity has been widely demonstrated in the literature to have considerable physical benefits (reduced risk of hypertension, vascular accidents, diabetes, improved bone condition, weight control, etc.) but also psychological benefits. However, according to the WHO, nearly 31% of adults aged 15 and over were not physically active in 2008. Physical inactivity is considered the 4th leading risk factor for death in the world. It is estimated to be the main cause of 21 to 25% of breast and colon cancers.

The investigators therefore propose a feasibility study, interventional, with minimal risks and constraints, evaluating the effectiveness of adapted physical activity in chronic pain related to a pathology little studied in this field of management: multiple myeloma. This study will include about 15 patients with residual pain 3 months after the end of their induction chemotherapy treatment.

Adapted Physical Activity sessions will be performed for 12 weeks. The evaluation of the expected benefits on pain and its consequences (cognitive, emotional, behavioral, physical ...) will be done through simple and validated questionnaires as well as on the evolution of the consumption of analgesics. The expected duration of the study will be one year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Myeloma Adapted Physical Activity Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adapted Physical Activity

Patients benefiting from adapted physical activity

Group Type EXPERIMENTAL

adapted physical activity

Intervention Type OTHER

3 sessions of adapted physical activity per week during 12 weeks for each patient

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

adapted physical activity

3 sessions of adapted physical activity per week during 12 weeks for each patient

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with chronic pain related to multiple myeloma, which has been evolving for more than 3 months and whose intensity is assessed with a VAS \> 30/100

* Patients who have completed more than 3 months of induction chemotherapy for Multiple Myeloma.
* Patients not eligible for bone marrow transplantation.
* Patient able to read, understand French and self-assess their pain on the VAS
* Patient followed in the haematology department of the Caen University Hospital and living in Calvados

Exclusion Criteria

* Patients with absolute contraindications to Adapted Physical Activity.

* Unstable angina
* Decompensated heart failure
* Complex ventricular rhythm disorders
* Severe uncontrolled hypertension
* PAH \> 60mmHg
* Presence of large or pedunculated intra-cavity thrombus
* Acute pericardial effusion
* Severe obstructive cardiomyopathy
* Tight and/or symptomatic aortic stenosis
* Recent thrombophlebitis with or without pulmonary embolism
* Diabetes with plantar perforating disease for activities involving the lower limbs
* Patient eligible for a bone marrow transplant.
* Patients with a major and/or potentially dangerous osteolytic lesion.
* Patients who do not meet the criteria for "moderate" functional impairment (assessed at the inclusion visit). defined by the HAS in 2019
* Pregnant or lactating woman.
* Minor patient.
* Patient under legal protection.
* Patient who does not read or understand French.
* Patient undergoing physiotherapy at the time of inclusion.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Caen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A02599-30

Identifier Type: REGISTRY

Identifier Source: secondary_id

20-163

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.